Fig. 1 · Structure

Documents & Downloads

CAY10505

Cat. No. A11196 CAS 1218777-13-9

PI3K inhibitor

CAY10505 is a potent inhibitor of PI3K, selectively inhibiting the γ isoform (IC50 = 30 nM) better than the α, β, and δ isoforms (IC50 = 0.94, 20, and 20 μM, respectively).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PI3Kγ 30 nM (IC50, Neurons)

Cellular Effect

Cell Line Activity Value Description Reference
MCF7 IC50 36.9 μM Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay [PMID: 20178321]

CAY10505 Research Summary

This section summarizes 4 in vitro studies of CAY10505 from 3 published references. In vitro models include ZR-75-1 cells; primary cultured cortical neurons.

CAY10505 In Vitro Studies

In ZR-75-1 cells assessed by qRT-PCR, CAY10505 reversed the miR-1976 inhibitor-induced increase in PIK3CG expression. In primary cultured cortical neurons, CAY10505 pretreatment partially reduced baicalein-induced Akt phosphorylation. Among HBE cells challenged with CSE, GPT2 mRNA expression was significantly lower with CAY10505. The study measuring PIK3CG, AKT, and p-AKT by western blot also reported that CAY10505 reversed the miR-1976 inhibitor-induced increase in PIK3CG mRNA and protein levels in ZR-75-1 cells. [1,2,3]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

PIK3CG mRNA expression following inhibitor treatment

Cell-based study · ZR-75-1 cells [1]

In ZR-75-1 cells, the miR-1976 inhibitor increased PIK3CG mRNA and protein levels, and CAY10505 reversed this effect. PIK3CG mRNA expression was measured by qRT-PCR.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
The mRNA expression of PIK3CG was measured by qRT-PCR.Reported result miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505[1]

Literature-Reported Treatment Conditions

Co-treatment
Other interventions in this design: miR-1976 inhibitor. Compound effect isolated by the comparison: miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505.
Reported limits
Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: CAY10505

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)

The mRNA expression of PIK3CG was measured by qRT-PCR.: The mRNA expression of PIK3CG was measured by qRT-PCR.; comparator: miR-1976 inhibitor — Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)

Partial Reduction of Baicalein-Induced Akt Phosphorylation in Cortical Neurons

Cell-based study · primary cultured cortical neurons [2]

In primary cultured cortical neurons, the tested compound at 200 nM with 1 h pretreatment partially reduced baicalein-induced Akt phosphorylation compared with the BA-treated group, as assessed by Western blotting of pAkt and Akt.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Western blotting of pAkt and AktReported result partially reduced the baicalein-induced Akt phosphorylation[2]

Literature-Reported Treatment Conditions

Treatment concentration
200 nM
Exposure duration
1 h pretreatment; 30 min after the BA treatment
Co-treatment
Other interventions in this design: BA 3.5 μM. Compound effect isolated by the comparison: with or without 1 h pretreatment.
Reported limits
Not stated in the sentences used: route, vehicle.
Methods and source locations

Compound reported in the paper: CAY10505

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Baicalein activates HIF1α to increase Epo and VEGF expression in cortical neurons (S78); Results > Baicalein activates Epo and VEGF gene transcription via class I PI3K/Akt/HIF-1α signaling pathway in cortical neurons (S97); Figure 3 legend (S155, S156, S159)

Western blotting of pAkt and Akt: Western blotting of pAkt and Akt; comparator: BA-treated group — Results > Baicalein activates Epo and VEGF gene transcription via class I PI3K/Akt/HIF-1α signaling pathway in cortical neurons (S97); Figure 3 legend (S156)

Lower GPT2 mRNA Expression in CSE-Challenged HBE Cells

Cell-based study · HBE cells [3]

In HBE cells challenged with CSE, treatment with the tested compound was associated with significantly lower GPT2 mRNA expression compared with cells challenged with CSE.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
mRNA expression of GPT2Reported result GPT2 expression was significantly lower[3]

Literature-Reported Treatment Conditions

Co-treatment
Other interventions in this design: CSE. Compound effect isolated by the comparison: When compared amongst cells challenged with CSE.
Reported limits
Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: CAY10505

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > Interactions between target genes and PI3K signalling pathway (S187, S189); FIGURE 8 legend (S270)

mRNA expression of GPT2: mRNA expression of GPT2; comparator: cells challenged with CSE — RESULTS > Interactions between target genes and PI3K signalling pathway (S189); FIGURE 8 legend (S270)

Protein expression following inhibitor treatment

Cell-based study · ZR-75-1 cells [1]

In ZR-75-1 cells, the miR-1976 inhibitor increased PIK3CG mRNA and protein levels, and CAY10505 reversed this effect. Western blotting measured PIK3CG, AKT, and p-AKT protein expression.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
The protein expression levels of PIK3CG, AKT, and p-AKT were measured by western blot.Reported result miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505[1]

Literature-Reported Treatment Conditions

Co-treatment
Other interventions in this design: miR-1976 inhibitor. Compound effect isolated by the comparison: miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505.
Reported limits
Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: CAY10505

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)

The protein expression levels of PIK3CG, AKT, and p-AKT were measured by western blot.: The protein expression levels of PIK3CG, AKT, and p-AKT were measured by western blot.; comparator: miR-1976 inhibitor — Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1218777-13-9
Applications PI3K inhibitor
Formula C14H8FNO3S
Molecular Weight 289.28
SMILES
C1=CC(=CC=C1C2=CC=C(O2)/C=C/3\C(=O)NC(=O)S3)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 53 mg/mL (183.21 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

CAY10505 Research References

  1. [1] Wang J, Li M, Han X, et al. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis. Cell Death Dis (2020). PMID: 32620748 DOI: 10.1038/s41419-020-2711-x Source material
  2. [2] Sun YY, Lin SH, Lin HC, et al. Cell type-specific dependency on the PI3K/Akt signaling pathway for the endogenous Epo and VEGF induction by baicalein in neurons versus astrocytes. PLoS One (2013). PMID: 23904909 DOI: 10.1371/journal.pone.0069019 Source material
  3. [3] Yan F, Zhang L, Duan L, et al. Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking. Clin Transl Med (2024). PMID: 38706045 DOI: 10.1002/ctm2.1679 Source material

Added to your cart

View Cart Checkout
Loading...